23:26
Unknown
Ranbaxy Laboratories, one of the India’s largest pharmaceutical company, has launched Infimab, the first ‘Remicade (Infliximab) biosimilar in India. The product was launched at the Indian Rheumatology Association Conference (IRACON) in Chandigarh, in the presence of over a thousand rheumatologists and doctors from around the country.
Real Time News & Trading Trends Keep Liking #EpicResearch
Facebook – Twitter – YouTube – Pinterest –Linkedin – Google+
For more information ✆ – 0731-6642300 or Visithttp://ift.tt/1k8NnLH
Posted in: Indian Market Tips
0 comments:
Post a Comment